Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Perceptions of Artificial Intelligence Among Pulmonologists
0
Zitationen
2
Autoren
2025
Jahr
Abstract
<title>Extract</title> Artificial intelligence (AI) applications are being increasingly deployed within medical specialties, including pulmonology [1]. An early role for these applications within pulmonology lies in lung nodule management [2]. This is especially important for interventional pulmonologists (IP) and advanced diagnostic bronchoscopists (ADB). There are an estimated 1.6 million lung nodules identified annually in the United States, and management remains a challenge [3]. Thus, there is an increasing relevance of AI applications that aid in lung nodule detection, tracking, and risk characterization. Also, experimental reports have demonstrated autonomous medical needle steering in-vivo in animals <italic>i.e.</italic> AI-aided navigational bronchoscopy [4]. As the adoption of AI increases in pulmonology, it is essential that healthcare professionals (HCPs) are familiar with AI-related terms, technologies, and their advantages and disadvantages. Accordingly, a survey was conducted to assess the perspectives of IP and ADB HCPs regarding the integration of AI into their clinical practice.
Ähnliche Arbeiten
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.858 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.978 Zit.
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 · 8.223 Zit.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 · 6.494 Zit.
Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
2016 · 5.741 Zit.